NephRx receives new U.S. patent for NX002 to treat IBD - 研发专利新闻

添加时间:2011-04-07 原文发表:2011-03-24 人气:2

NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease (IBD). Animal studies suggest that NX002 may have applications in...

查看所有的文章内容需要 VIP会员权限查看

点这里复制本页地址发送给您QQ/MSN上的好友

• USPTO grants patent to ULURU's Altrazeal

• NephRx receives new U.S. patent for NX00

• PRWP receives two new patents for Galect

• POZEN files motion for Treximet patent l

• BDSI's BEMA drug delivery technology rec

• USPTO grants patent to HistoRx methods f

• GenSpera strengthens intellectual proper

• USPTO rejects Biotage's re-examination a

• HPK receives Reissue Patent for digital

• Global settlement agreement reached in T

• ACT to be awarded broad patent protectio

• Colorcon announces specific details on i

• VARI, Gentel Biosciences receive U.S. Pa

• USPTO issues Notice of Allowance to Alph

• US District Court rules against Watson i

• U.S. District Court rules in favor of Wa

• Biotectix acquires Chameleon BioSurfaces

• USPTO issues Notice of Allowance to Modu

• USPTO issues patent to Somaxon's Silenor

• USPTO grants composition-of-matter paten

网站首页

行业信息

市场快讯

SFDA新闻精选

调研报告

研发动态

研发专利新闻

新闻公告

您的位置：网站名称 → 研发专利新闻 → 正文